Lo Andrew 4
4 · BridgeBio Pharma, Inc. · Filed Jun 23, 2023
Insider Transaction Report
Form 4
Lo Andrew
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-21+51,501→ 51,501 totalExercise: $16.75Exp: 2033-06-21→ Common Stock (51,501 underlying)
Footnotes (1)
- [F1]1/3rd of the shares underlying the option will vest on June 21, 2024; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company.